Clinically localised prostate cancer
- PMID: 17124221
- PMCID: PMC1661729
- DOI: 10.1136/bmj.39022.423588.DE
Clinically localised prostate cancer
Conflict of interest statement
Competing interests: Both authors are chairmen of randomised trials of prostate cancer treatment and prevention referred to in the article.
Figures
References
-
- Gronberg H. Prostate cancer epidemiology. Lancet 2003;361:859-64. - PubMed
-
- Baillargeon J, Rose DP. Obesity, adipokines, and prostate cancer (review). Int J Oncol 2006;28:737-45. - PubMed
-
- Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 2005;97:1768-77. - PubMed
-
- Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24. - PubMed
-
- Young JM, Muscatello DJ, Ward JE. Are men with lower urinary tract symptomas at increased risk of prostate cancer? A systematic review and critique of the available evidence. BJU Int 2000;85:1037-48. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical